CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+10.99%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$10.6B
AUM Growth
+$1.15B
(+12%)
Cap. Flow
+$331M
Cap. Flow
% of AUM
3.12%
Top 10 Holdings %
Top 10 Hldgs %
22.38%
Holding
858
New
50
Increased
272
Reduced
342
Closed
45
Top Buys
| 1 |
Amgen
AMGN
|
$99.4M |
| 2 |
Merck
MRK
|
$74.3M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$52.7M |
| 4 |
Thermo Fisher Scientific
TMO
|
$36.6M |
| 5 |
Danaher
DHR
|
$36.3M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$86.9M |
| 2 |
Apple
AAPL
|
$60.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$31.9M |
| 4 |
Kimberly-Clark
KMB
|
$28.1M |
| 5 |
Arista Networks
ANET
|
$21.4M |
Sector Composition
| 1 | Healthcare | 35.9% |
| 2 | Technology | 20.42% |
| 3 | Consumer Discretionary | 9.53% |
| 4 | Communication Services | 7.72% |
| 5 | Financials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Dell
DELL
$84.4B
| $5.55M | 0.05% |
161,622
-14,644
| -8% | -$502K |
|
327
Target
TGT
$42.3B
| $5.51M | 0.05% |
35,018
-1,748
| -5% | -$275K |
|
328
Domino's
DPZ
$15.7B
| $5.51M | 0.05% |
12,960
-118
| -0.9% | -$50.2K |
|
329
Ameriprise Financial
AMP
$46.1B
| $5.46M | 0.05% |
35,418
-37,907
| -52% | -$5.84M |
|
330
Kinross Gold
KGC
$26.9B
| $5.44M | 0.05% |
453,153
-38,990
| -8% | -$468K |
|
331
Royal Bank of Canada
RY
$204B
| $5.43M | 0.05% |
77,588
+9,076
| +13% | +$635K |
|
332
Eversource Energy
ES
$23.6B
| $5.43M | 0.05% |
64,936
-26,653
| -29% | -$2.23M |
|
333
PVH
PVH
$4.22B
| $5.4M | 0.05% |
90,497
-9,632
| -10% | -$574K |
|
334
Roper Technologies
ROP
$55.8B
| $5.38M | 0.05% |
13,623
-551
| -4% | -$218K |
|
335
Clorox
CLX
$15.5B
| $5.38M | 0.05% |
25,604
+14,320
| +127% | +$3.01M |
|
336
Otis Worldwide
OTIS
$34.1B
| $5.37M | 0.05% |
86,002
+56,008
| +187% | +$3.5M |
|
337
Ormat Technologies
ORA
$5.51B
| $5.32M | 0.05% |
89,934
+1,882
| +2% | +$111K |
|
338
Syndax Pharmaceuticals
SNDX
$1.47B
| $5.29M | 0.05% |
358,372
+10,914
| +3% | +$161K |
|
339
Zions Bancorporation
ZION
$8.34B
| $5.28M | 0.05% |
180,645
-74,558
| -29% | -$2.18M |
|
340
Novavax
NVAX
$1.28B
| $5.26M | 0.05% |
+48,575
| New | +$5.26M |
|
341
Nektar Therapeutics
NKTR
$764M
| $5.24M | 0.05% |
21,062
| – | – |
|
342
Consolidated Edison
ED
$35.4B
| $5.04M | 0.05% |
64,767
+657
| +1% | +$51.1K |
|
343
PNC Financial Services
PNC
$80.5B
| $5.02M | 0.05% |
45,707
+9,668
| +27% | +$1.06M |
|
344
Zoetis
ZTS
$67.9B
| $4.99M | 0.05% |
30,192
-2,053
| -6% | -$340K |
|
345
FedEx
FDX
$53.7B
| $4.93M | 0.05% |
19,586
-2,354
| -11% | -$592K |
|
346
Manulife Financial
MFC
$52.1B
| $4.92M | 0.05% |
355,119
+15,298
| +5% | +$212K |
|
347
Micron Technology
MU
$147B
| $4.91M | 0.05% |
104,639
+14,732
| +16% | +$692K |
|
348
Baker Hughes
BKR
$44.9B
| $4.84M | 0.05% |
364,360
+31,634
| +10% | +$420K |
|
349
Telus
TU
$25.3B
| $4.84M | 0.05% |
276,066
+113,669
| +70% | +$1.99M |
|
|
PVLA
350
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $4.78M | 0.04% |
28,848
-470
| -2% | -$77.8K |
|